Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$155.75 - $174.48 $200,606 - $224,730
1,288 New
1,288 $200,000
Q1 2023

May 02, 2023

SELL
$151.05 - $180.26 $100,599 - $120,053
-666 Reduced 33.77%
1,306 $202,000
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $10,252 - $11,506
-64 Reduced 3.14%
1,972 $0
Q3 2022

Oct 18, 2022

BUY
$161.33 - $179.52 $2,419 - $2,692
15 Added 0.74%
2,036 $333,000
Q2 2022

Jul 13, 2022

BUY
$168.19 - $186.01 $67,780 - $74,962
403 Added 24.91%
2,021 $359,000
Q1 2022

Apr 29, 2022

BUY
$158.14 - $179.59 $18,976 - $21,550
120 Added 8.01%
1,618 $287,000
Q4 2021

Jan 26, 2022

SELL
$155.93 - $173.01 $115,544 - $128,200
-741 Reduced 33.1%
1,498 $256,000
Q3 2021

Oct 15, 2021

BUY
$161.5 - $179.47 $23,256 - $25,843
144 Added 6.87%
2,239 $362,000
Q2 2021

Jul 21, 2021

BUY
$159.48 - $171.07 $334,110 - $358,391
2,095 New
2,095 $345,000
Q1 2021

Apr 14, 2021

SELL
$153.07 - $170.48 $323,130 - $359,883
-2,111 Closed
0 $0
Q4 2020

Jan 19, 2021

SELL
$137.11 - $157.38 $41,133 - $47,214
-300 Reduced 12.44%
2,111 $332,000
Q3 2020

Oct 22, 2020

BUY
$140.38 - $153.83 $7,720 - $8,460
55 Added 2.33%
2,411 $359,000
Q1 2020

Apr 28, 2020

BUY
$111.14 - $153.99 $1,778 - $2,463
16 Added 0.68%
2,356 $309,000
Q4 2019

Feb 04, 2020

SELL
$127.5 - $146.44 $637 - $732
-5 Reduced 0.21%
2,340 $341,000
Q3 2019

Oct 29, 2019

BUY
$126.95 - $142.14 $19,042 - $21,320
150 Added 6.83%
2,345 $303,000
Q2 2019

Jul 16, 2019

SELL
$131.15 - $144.24 $3,934 - $4,327
-30 Reduced 1.35%
2,195 $306,000
Q1 2019

Apr 30, 2019

BUY
$125.72 - $139.79 $279,727 - $311,032
2,225 New
2,225 $311,000
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $186,593 - $224,568
-1,519 Closed
0 $0
Q3 2018

Nov 01, 2018

SELL
$121.58 - $142.88 $68,571 - $80,584
-564 Reduced 27.08%
1,519 $210,000
Q2 2018

Aug 07, 2018

BUY
$119.4 - $131.76 $248,710 - $274,456
2,083 New
2,083 $253,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Youngs Advisory Group, Inc. Portfolio

Follow Youngs Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Youngs Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Youngs Advisory Group, Inc. with notifications on news.